drugset / Trial / NCT00135473
Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)
Phase 3
Completed
600 enrolled
SepNet - Critical Care Trials Group
B. Braun Melsungen AG · collabGerman Federal Ministry of Education and Research · collabHemoCue · collabNovo Nordisk A/S · collab
RandomizedFactorialOpen-labelTreatment
Summary
The purpose of this trial is to determine the influence of colloid versus crystalloid volume resuscitation and of intensive vs conventional insulin therapy on morbidity and mortality of patients with severe sepsis and septic shock.
Timeline
- Start
- 2003-04
- Primary completion
- —
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hemohes | Unknown | 10 % | — |
| Subject | Insulin | Protein / enzyme biologic | — | — |
| Subject | Sterofundin | Unknown | — | — |